Tamron Co., Ltd. Full-Year Earnings Flash

Revenue-growth businesses offset lower OEM shipments in photography-related products and a stronger yen headwind; FY12/26 plan calls for revenue of JPY 91B and operating income of JPY 18.5B

February 9, 2026 at 14:45 GMT+9

Key Positives From The Results

Even amid a challenging external environment for photography-related products, we view it positively that growth areas including automotive and medical functioned as an earnings backstop, keeping Operating Income Margin at a high 19.6%. Mobility & Healthcare and Other expanded to revenue of JPY 12,336M (+8.9% YoY) and operating income of JPY 2,699M (+9.0% YoY), confirming continued progress in business portfolio diversification.

  • Mobility & Healthcare And Other Delivered Higher Revenue And Profit: Revenue of JPY 12,336M (+8.9% YoY) and operating income of JPY 2,699M (+9.0% YoY) remained solid
  • Surveillance & FA Profitability Improved: Despite revenue of JPY 12,091M (-1.8% YoY), operating income rose to JPY 1,675M (+7.0% YoY)
  • Maintained High Profitability: Even with revenue down to JPY 85,071M (-3.8% YoY), the company delivered Operating Income Margin of 19.6% (-2.1pt YoY)
  • Continued Balance Sheet Headroom: Equity ratio remained high at 81.0% (+0.4pt YoY) and interest coverage ratio at 199.0x
  • Continued Shareholder Returns And Capital Policy: Despite weaker earnings, dividends were paid as initially planned with a 50% payout ratio; share buybacks were executed at ~2x the prior-year scale, lifting total payout ratio to 80%+

Key Concerns From The Results

Despite ongoing cost-down efforts, operating income declined to JPY 16,638M (-13.4% YoY) as lower revenue, higher raw materials and utilities costs, higher labor costs, and increased R&D expenses weighed on profitability. Lower OEM shipments in the photography-related business and FX (JPY appreciation vs. USD) constrained growth in the core business.

  • Photography-Related Business Revenue/Profit Declined: Revenue of JPY 60,643M (-6.5% YoY) and operating income of JPY 15,630M (-13.7% YoY) was the primary driver of the consolidated profit decline
  • Decline In Consolidated Profit: Operating income JPY 16,638M (-13.4% YoY), recurring profit JPY 16,699M (-13.5% YoY), net income attributable to owners of parent company JPY 11,761M (-19.0% YoY)
  • Continued Increases In R&D And SG&A: Technical R&D expense rose to JPY 7,313M (+3.1% YoY) and total SG&A increased to JPY 20,779M (+2.9% YoY)
  • Expanded FX Losses: FX losses widened to JPY 439M (+JPY 281M YoY), pressuring non-operating items
  • Lower Cash Generation And Higher Capital Policy Burden: Operating CF JPY 15,096M (-14.4% YoY), financing CF JPY -11,129M (outflows increased YoY), ending cash and cash equivalents JPY 35,371M (-JPY 3,012M YoY)

Focus Areas / Items To Monitor Going Forward

  • Assess whether photography-related OEM demand can recover, and the extent to which higher new product launches under the in-house brand can drive volume and mix improvement
  • Timing of demand recovery in Surveillance & FA after inventory adjustments unwind, and progress in catching up on delayed launches of new camera module models
  • Verify whether pipeline build in automotive (ADAS) and medical (ultra-small diameter and thin-film technologies) can translate into sustained growth even after surpassing revenue milestones of JPY 10B / JPY 1B
Discussion Points For Management
  • Breakdown of the drivers behind the photography-related OEM revenue decline (weak sell-through of ordered models, inventory, customer-specific factors) and assumptions embedded in FY12/26
  • Recalibration of marketing and channel strategy by region given the in-house brand trend (Japan/US/India up, Europe/China soft)
  • Priority areas for higher R&D spend (technical R&D expense of JPY 7.3B) and the expected timeline to revenue contribution
  • Drivers of gross margin improvement in Surveillance & FA (product mix, cost reductions, price revisions) and sustainability
  • Management’s view on when FA/machine vision inventory adjustment will normalize, and leading indicators for order recovery
  • Root causes of camera module development delays, and management’s assessment of customer specification requirements and resource allocation issues
  • Breakdown of growth drivers after reaching the “first JPY 10B” in automotive lenses (number of adopted items, units installed, ASP)
  • Key end-uses and customer mix behind the “first JPY 1B” in medical lenses, and plans to expand mass-production capacity
  • Sensitivity and hedging policy versus FX assumptions (FY12/26: USD 1 = JPY 148, EUR 1 = JPY 175)
  • Policy on share repurchases and cancellations (pace, target level) and balancing shareholder returns with growth investment

Key Financial Highlights

ItemValueYoY
RevenueJPY 85,071M-3.8%
Gross ProfitJPY 37,417M-5.0%
Gross Profit Margin44.0%-0.5pt
SG&AJPY 20,779M+2.9%
Operating IncomeJPY 16,638M-13.4%
Operating Income Margin19.6%-2.1pt
Recurring ProfitJPY 16,699M-13.5%
Net Income Attributable to Owners of Parent CompanyJPY 11,761M-19.0%
EPSJPY 72.79-17.2%
Comprehensive IncomeJPY 13,339M-25.5%
Total AssetsJPY 106,046M+3.8%
Net AssetsJPY 85,911M+4.3%
Equity Ratio81.0%+0.4pt
Ending Cash and Cash EquivalentsJPY 35,371M-7.8%
Operating CFJPY 15,096M-14.4%
Investing CFJPY -7,339MOutflows Increased
Financing CFJPY -11,129MOutflows Increased

Performance By Business Segment

SegmentRevenueYoYOperating IncomeYoYMargin
Photography-Related BusinessJPY 60,643M-6.5%JPY 15,630M-13.7%25.8%
Surveillance & FA-Related BusinessJPY 12,091M-1.8%JPY 1,675M+7.0%13.9%
Mobility & Healthcare And OtherJPY 12,336M+8.9%JPY 2,699M+9.0%21.9%
Adjustments--JPY -3,367M--
Consolidated TotalJPY 85,071M-3.8%JPY 16,638M-13.4%19.6%
Strong Performers
  • Mobility & Healthcare And Other: Revenue +8.9% YoY; automotive revenue rose on expanded sensing applications driven by ADAS penetration, and medical revenue grew ~1.5x QoQ to reach a first JPY 1B
  • Surveillance & FA-Related Business (Profit): Despite revenue -1.8% YoY, operating income +7.0% YoY, driven by improved gross margin and SG&A restraint
Underperformers
  • Photography-Related Business: Revenue -6.5% YoY, weighed down by lower OEM shipments and stagnation in certain markets
  • Surveillance & FA-Related Business (Revenue): FA/machine vision declined due to customer inventory adjustments, and camera modules declined due to delays in new model development

Changes To Guidance

The company disclosed only its FY12/26 plan (revenue JPY 91B, operating income JPY 18.5B, recurring profit JPY 18.5B, net income attributable to owners of parent company JPY 13.69B). FX assumptions are USD 1 = JPY 148 and EUR 1 = JPY 175.

Commentary On Shareholder Returns

FY12/26 dividend guidance is JPY 37.00 per share annually (interim JPY 10.50, year-end JPY 26.50). For FY12/25, on an adjusted basis reflecting the impact of the stock split, the annual dividend was equivalent to JPY 36.25 (interim JPY 10.00, year-end JPY 26.25), positioning the FY12/26 plan as maintaining to slightly increasing the dividend level.

Financial Position

The company maintained a high equity ratio of 81.0%, sustaining an effectively low-leverage balance sheet. Capital allocation remains in a phase of building investment securities and advancing capex while simultaneously executing dividends and share repurchases.

  • Key Figures
  • Leverage Metrics
ItemValueAdditional Information
Cash and Cash EquivalentsJPY 35,371M-7.8% vs. prior FY
Total AssetsJPY 106,046M+3.8% vs. prior FY
Net AssetsJPY 85,911M+4.3% vs. prior FY
Shareholders' EquityJPY 85,911M+4.3% vs. prior FY
Interest-Bearing DebtJPY 1,045MShort-term borrowings 798 + long-term borrowings 247
└ Short-term BorrowingsJPY 798M-56.9% vs. prior FY
└ Long-term BorrowingsJPY 247M-33.1% vs. prior FY
Investment SecuritiesJPY 8,997M+34.3% vs. prior FY
Tangible Fixed AssetsJPY 20,335M+6.2% vs. prior FY
EBITDAJPY 20,161MOperating income 16,638 + depreciation and amortization 3,523 (our estimate)

News Released Alongside The Earnings Announcement

  • None

Major Announcements During The Quarter

  • 2025/12/04
    Announced a firmware (Ver. 4) update for “150-500mm F5-6.7 (Model A057)” (Notice Regarding the “150-500mm F5-6.7 (Model A057)” Firmware (Ver. 4) Update) (https://www.tamron.com/jp/consumer/news/2025/) tamron.com
  • 2025/10/21
    Announced the high-magnification zoom “25-200mm F/2.8-5.6 Di III VXD G2 (Model A075)” to launch on 11/20, highlighting the 25mm wide end and AF performance (Starting at 25mm F2.8 on the wide end. Enhanced optics and AF performance high-magnification zoom lens. 25-200mm F2.8-5.6 G2 (Model A075) for Sony E-mount to be released on November 20, 2025) (https://www.tamron.com/jp/consumer/news/detail/a075_20251021.html) tamron.com
  • 2025/10/07
    Announced the release of “70-180mm F2.8 G2 (Model A065)” for Nikon Z mount, highlighting built-in image stabilization and a compact/lightweight design (Notice of Release of the Class’s Smallest and Lightest* 70-180mm F2.8 G2 (Model A065) for Nikon Z Mount Featuring an Image Stabilization Mechanism) (https://www.tamron.com/jp/consumer/news/detail/a065z_20251007.html) tamron.com

Large-Shareholding Filings / Material Proposals Over The Past Year

  • Effissimo Capital Management: 13.06%→14.12% (effective date 2025/12/03, filed 2025/12/10) - increased ownership ratio due to additional purchases (position added)
  • Effissimo Capital Management: 12.04%→13.06% (effective date 2025/10/16, filed 2025/10/23) - increased ownership ratio due to additional purchases
  • Resona Asset Management: change report above 5% (effective date 2025/06/13, filed 2025/06/20) - change in ownership ratio (position adjustment)
Disclaimer

Envalith, Inc. ("Envalith") provides exclusive research coverage services to domestic and international institutional investors, as well as domestic individual investors, with the objective of contributing to the development of global and Japanese capital markets by providing information necessary for considering investments in Japanese listed companies.

  • Purpose and Disclaimer Regarding Investment Decisions

    This report has been prepared solely for informational purposes and does not constitute a solicitation to acquire, sell, or hold securities or any other financial products. Furthermore, this report does not constitute specific investment, financial, or tax advice. Any opinions, judgments, or recommendations contained herein are not intended to induce investment activities. Please be advised that all investment decisions must be made based on the investor's own responsibility and judgment, and Envalith and subject company shall not be involved in any such investment decisions.

  • Information Sources, Accuracy, and Disclaimer of Warranty

    This report has been prepared based on a formal request from the subject company, utilizing information provided by and interviews conducted with said company. By using this report, you are deemed to have agreed to the following: 1. Information Sources: This report is prepared on the assumption that the publicly available information and information disclosed by the subject company and provided during interviews is true and reliable. Envalith has not independently verified or validated the veracity of such information. 2. Accuracy: The interpretations, analyses, and hypotheses or conclusions based thereon contained in this report are independently derived by Envalith using its own perspectives and analytical methods based on the information mentioned in the preceding paragraph. 3. Disclaimer of Warranty: In the event that there are errors or omissions in the information disclosed by the subject company, Envalith and subject company shall not be held liable for any inaccuracies in this report resulting therefrom. Envalith and subject company make no warranties, whether express or implied, regarding the accuracy, safety, validity, completeness, or any other aspect of this report, nor regarding the past or future performance of the subject company.

  • Limitation of Liability

    Envalith and subject company shall not be liable for any costs, damages, or losses (including direct, indirect, incidental, consequential, or punitive damages) arising from the use of this report or the information obtained therefrom. Users of this report acknowledge and agree that such use is at their own risk.

  • Potential Conflicts of Interest

    Envalith may have, or may have in the future, business relationships with the subject company. Accordingly, investors should be aware that conflicts of interest may exist that could affect the objectivity of this report.

  • No Obligation to Change or Update Content

    The contents and opinions in this report, as well as the information upon which it is based, are current as of the date of preparation and are subject to change without notice. Please be advised that Envalith is under no obligation to update the contents of this report, and investors must verify the timeliness of the information on their own.

  • Governing Language

    This report is prepared in Japanese, English, and Chinese. In the event of any discrepancy or difference in interpretation between the language versions, the Japanese version shall be treated as the original and shall prevail.

  • Copyright

    All rights (including copyrights) relating to this report belong to Envalith. Any reproduction, redistribution, or other use of all or part of this report without the prior written permission of Envalith is strictly prohibited.

  • Use for Other Investment Products

    Except where Envalith has provided prior written approval, the use of this report and the trademarks or trade names of Envalith or the subject company in connection with the information distribution, transaction, sales promotion, or advertising of any investment products (including derivatives, structured products, investment trusts, or investment assets whose price, return, or performance is based on or linked to this report) is strictly prohibited.